nodes	percent_of_prediction	percent_of_DWPC	metapath
Cinacalcet—CYP1A2—Leflunomide—rheumatoid arthritis	0.137	0.225	CbGbCtD
Cinacalcet—CYP3A4—Ergocalciferol—rheumatoid arthritis	0.0792	0.13	CbGbCtD
Cinacalcet—CYP3A4—Methylprednisolone—rheumatoid arthritis	0.0584	0.096	CbGbCtD
Cinacalcet—CYP2D6—Cyclosporine—rheumatoid arthritis	0.0528	0.0867	CbGbCtD
Cinacalcet—CYP3A4—Triamcinolone—rheumatoid arthritis	0.0443	0.0728	CbGbCtD
Cinacalcet—CYP3A4—Betamethasone—rheumatoid arthritis	0.038	0.0624	CbGbCtD
Cinacalcet—CYP3A4—Prednisolone—rheumatoid arthritis	0.0375	0.0616	CbGbCtD
Cinacalcet—CYP3A4—Hydrocortisone—rheumatoid arthritis	0.0355	0.0584	CbGbCtD
Cinacalcet—CYP3A4—Prednisone—rheumatoid arthritis	0.0354	0.0582	CbGbCtD
Cinacalcet—CYP2D6—Dexamethasone—rheumatoid arthritis	0.0347	0.0571	CbGbCtD
Cinacalcet—CYP3A4—Cyclosporine—rheumatoid arthritis	0.0336	0.0552	CbGbCtD
Cinacalcet—CYP3A4—Dexamethasone—rheumatoid arthritis	0.0221	0.0363	CbGbCtD
Cinacalcet—CASR—Gastrin-CREB signalling pathway via PKC and MAPK—SAA1—rheumatoid arthritis	0.00138	0.0147	CbGpPWpGaD
Cinacalcet—CASR—G alpha (q) signalling events—BDKRB2—rheumatoid arthritis	0.00134	0.0143	CbGpPWpGaD
Cinacalcet—CASR—G alpha (q) signalling events—ADRBK1—rheumatoid arthritis	0.00133	0.0141	CbGpPWpGaD
Cinacalcet—CASR—G alpha (i) signalling events—CXCL2—rheumatoid arthritis	0.00132	0.014	CbGpPWpGaD
Cinacalcet—CASR—G alpha (i) signalling events—SAA1—rheumatoid arthritis	0.00129	0.0137	CbGpPWpGaD
Cinacalcet—CASR—G alpha (q) signalling events—RASGRP1—rheumatoid arthritis	0.00125	0.0133	CbGpPWpGaD
Cinacalcet—CASR—G alpha (q) signalling events—PRKCQ—rheumatoid arthritis	0.00123	0.013	CbGpPWpGaD
Cinacalcet—CASR—Gastrin-CREB signalling pathway via PKC and MAPK—BDKRB2—rheumatoid arthritis	0.0012	0.0128	CbGpPWpGaD
Cinacalcet—CASR—Gastrin-CREB signalling pathway via PKC and MAPK—ADRBK1—rheumatoid arthritis	0.00119	0.0126	CbGpPWpGaD
Cinacalcet—CASR—Gastrin-CREB signalling pathway via PKC and MAPK—RASGRP1—rheumatoid arthritis	0.00112	0.0119	CbGpPWpGaD
Cinacalcet—CASR—G alpha (i) signalling events—BDKRB2—rheumatoid arthritis	0.00112	0.0119	CbGpPWpGaD
Cinacalcet—CASR—G alpha (i) signalling events—CXCL12—rheumatoid arthritis	0.00112	0.0119	CbGpPWpGaD
Cinacalcet—CASR—GPCR ligand binding—CXCL13—rheumatoid arthritis	0.00112	0.0119	CbGpPWpGaD
Cinacalcet—CASR—Gastrin-CREB signalling pathway via PKC and MAPK—PRKCQ—rheumatoid arthritis	0.0011	0.0116	CbGpPWpGaD
Cinacalcet—CASR—GPCR downstream signaling—CXCL6—rheumatoid arthritis	0.00107	0.0114	CbGpPWpGaD
Cinacalcet—CASR—GPCR downstream signaling—CCL21—rheumatoid arthritis	0.00102	0.0109	CbGpPWpGaD
Cinacalcet—CASR—GPCR ligand binding—CX3CR1—rheumatoid arthritis	0.000997	0.0106	CbGpPWpGaD
Cinacalcet—CASR—G alpha (i) signalling events—CXCL10—rheumatoid arthritis	0.000989	0.0105	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—CXCL6—rheumatoid arthritis	0.000974	0.0103	CbGpPWpGaD
Cinacalcet—CASR—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—rheumatoid arthritis	0.000969	0.0103	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—CCL21—rheumatoid arthritis	0.000929	0.00987	CbGpPWpGaD
Cinacalcet—CASR—GPCR ligand binding—C5—rheumatoid arthritis	0.000927	0.00984	CbGpPWpGaD
Cinacalcet—CASR—GPCR ligand binding—CCR6—rheumatoid arthritis	0.000871	0.00926	CbGpPWpGaD
Cinacalcet—CASR—G alpha (i) signalling events—CCL5—rheumatoid arthritis	0.000851	0.00904	CbGpPWpGaD
Cinacalcet—CASR—GPCR downstream signaling—PDE2A—rheumatoid arthritis	0.000813	0.00863	CbGpPWpGaD
Cinacalcet—CASR—GPCR ligand binding—CXCL2—rheumatoid arthritis	0.000797	0.00847	CbGpPWpGaD
Cinacalcet—CASR—GPCR ligand binding—CCL3—rheumatoid arthritis	0.000797	0.00847	CbGpPWpGaD
Cinacalcet—CASR—GPCR ligand binding—SAA1—rheumatoid arthritis	0.000779	0.00828	CbGpPWpGaD
Cinacalcet—CASR—G alpha (i) signalling events—CCR5—rheumatoid arthritis	0.000767	0.00815	CbGpPWpGaD
Cinacalcet—CASR—G alpha (i) signalling events—C3—rheumatoid arthritis	0.00075	0.00796	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—PDE2A—rheumatoid arthritis	0.000738	0.00784	CbGpPWpGaD
Cinacalcet—CASR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6ST—rheumatoid arthritis	0.000704	0.00748	CbGpPWpGaD
Cinacalcet—CASR—GPCR ligand binding—CXCL12—rheumatoid arthritis	0.000678	0.0072	CbGpPWpGaD
Cinacalcet—CASR—GPCR ligand binding—BDKRB2—rheumatoid arthritis	0.000678	0.0072	CbGpPWpGaD
Cinacalcet—CYP1A2—Arachidonic acid metabolism—PTGES—rheumatoid arthritis	0.000642	0.00682	CbGpPWpGaD
Cinacalcet—CASR—GPCR downstream signaling—CXCL13—rheumatoid arthritis	0.000632	0.00671	CbGpPWpGaD
Cinacalcet—CASR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—rheumatoid arthritis	0.000628	0.00667	CbGpPWpGaD
Cinacalcet—CASR—G alpha (i) signalling events—POMC—rheumatoid arthritis	0.0006	0.00637	CbGpPWpGaD
Cinacalcet—CASR—GPCR ligand binding—CXCL10—rheumatoid arthritis	0.000599	0.00636	CbGpPWpGaD
Cinacalcet—Anorexia—Cyclosporine—rheumatoid arthritis	0.000577	0.00194	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—CXCL6—rheumatoid arthritis	0.000575	0.00611	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—CXCL13—rheumatoid arthritis	0.000574	0.0061	CbGpPWpGaD
Cinacalcet—CASR—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—rheumatoid arthritis	0.000572	0.00608	CbGpPWpGaD
Cinacalcet—Convulsion—Hydrocortisone—rheumatoid arthritis	0.000571	0.00192	CcSEcCtD
Cinacalcet—Hypertension—Hydrocortisone—rheumatoid arthritis	0.000569	0.00192	CcSEcCtD
Cinacalcet—Diarrhoea—Azathioprine—rheumatoid arthritis	0.000568	0.00191	CcSEcCtD
Cinacalcet—Angioedema—Triamcinolone—rheumatoid arthritis	0.000567	0.00191	CcSEcCtD
Cinacalcet—Angioedema—Methylprednisolone—rheumatoid arthritis	0.000566	0.00191	CcSEcCtD
Cinacalcet—Asthenia—Leflunomide—rheumatoid arthritis	0.000563	0.00189	CcSEcCtD
Cinacalcet—Myalgia—Hydrocortisone—rheumatoid arthritis	0.000561	0.00189	CcSEcCtD
Cinacalcet—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—rheumatoid arthritis	0.000557	0.00188	CcSEcCtD
Cinacalcet—Pruritus—Leflunomide—rheumatoid arthritis	0.000555	0.00187	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Cyclosporine—rheumatoid arthritis	0.000552	0.00186	CcSEcCtD
Cinacalcet—Dizziness—Azathioprine—rheumatoid arthritis	0.000549	0.00185	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—CCL21—rheumatoid arthritis	0.000549	0.00583	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—SYVN1—rheumatoid arthritis	0.000549	0.00583	CbGpPWpGaD
Cinacalcet—Upper respiratory tract infection—Methotrexate—rheumatoid arthritis	0.000547	0.00184	CcSEcCtD
Cinacalcet—Paraesthesia—Cyclosporine—rheumatoid arthritis	0.000544	0.00183	CcSEcCtD
Cinacalcet—CASR—GPCR downstream signaling—IL2RB—rheumatoid arthritis	0.000542	0.00576	CbGpPWpGaD
Cinacalcet—Cough—Triamcinolone—rheumatoid arthritis	0.000542	0.00182	CcSEcCtD
Cinacalcet—Dyspnoea—Cyclosporine—rheumatoid arthritis	0.00054	0.00182	CcSEcCtD
Cinacalcet—Convulsion—Triamcinolone—rheumatoid arthritis	0.000538	0.00181	CcSEcCtD
Cinacalcet—Diarrhoea—Leflunomide—rheumatoid arthritis	0.000537	0.00181	CcSEcCtD
Cinacalcet—Convulsion—Methylprednisolone—rheumatoid arthritis	0.000537	0.00181	CcSEcCtD
Cinacalcet—Hypertension—Triamcinolone—rheumatoid arthritis	0.000536	0.0018	CcSEcCtD
Cinacalcet—Hypertension—Methylprednisolone—rheumatoid arthritis	0.000535	0.0018	CcSEcCtD
Cinacalcet—Infection—Hydrocortisone—rheumatoid arthritis	0.000535	0.0018	CcSEcCtD
Cinacalcet—Dyspepsia—Cyclosporine—rheumatoid arthritis	0.000533	0.00179	CcSEcCtD
Cinacalcet—Myalgia—Triamcinolone—rheumatoid arthritis	0.000529	0.00178	CcSEcCtD
Cinacalcet—Vomiting—Azathioprine—rheumatoid arthritis	0.000528	0.00178	CcSEcCtD
Cinacalcet—Nervous system disorder—Hydrocortisone—rheumatoid arthritis	0.000528	0.00178	CcSEcCtD
Cinacalcet—Myalgia—Methylprednisolone—rheumatoid arthritis	0.000527	0.00178	CcSEcCtD
Cinacalcet—Arthralgia—Methylprednisolone—rheumatoid arthritis	0.000527	0.00178	CcSEcCtD
Cinacalcet—Decreased appetite—Cyclosporine—rheumatoid arthritis	0.000526	0.00177	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—TAGAP—rheumatoid arthritis	0.000526	0.00559	CbGpPWpGaD
Cinacalcet—Rash—Azathioprine—rheumatoid arthritis	0.000524	0.00176	CcSEcCtD
Cinacalcet—CASR—GPCR downstream signaling—C5—rheumatoid arthritis	0.000524	0.00556	CbGpPWpGaD
Cinacalcet—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—rheumatoid arthritis	0.000524	0.00176	CcSEcCtD
Cinacalcet—Dermatitis—Azathioprine—rheumatoid arthritis	0.000523	0.00176	CcSEcCtD
Cinacalcet—Depression—Methotrexate—rheumatoid arthritis	0.000523	0.00176	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Cyclosporine—rheumatoid arthritis	0.000523	0.00176	CcSEcCtD
Cinacalcet—Skin disorder—Hydrocortisone—rheumatoid arthritis	0.000523	0.00176	CcSEcCtD
Cinacalcet—Fatigue—Cyclosporine—rheumatoid arthritis	0.000522	0.00176	CcSEcCtD
Cinacalcet—Headache—Azathioprine—rheumatoid arthritis	0.00052	0.00175	CcSEcCtD
Cinacalcet—Dizziness—Leflunomide—rheumatoid arthritis	0.000519	0.00175	CcSEcCtD
Cinacalcet—Constipation—Cyclosporine—rheumatoid arthritis	0.000518	0.00174	CcSEcCtD
Cinacalcet—CASR—GPCR ligand binding—CCL5—rheumatoid arthritis	0.000516	0.00548	CbGpPWpGaD
Cinacalcet—Angioedema—Dexamethasone—rheumatoid arthritis	0.000515	0.00173	CcSEcCtD
Cinacalcet—Angioedema—Betamethasone—rheumatoid arthritis	0.000515	0.00173	CcSEcCtD
Cinacalcet—Anorexia—Hydrocortisone—rheumatoid arthritis	0.000513	0.00173	CcSEcCtD
Cinacalcet—CASR—Signaling by GPCR—CX3CR1—rheumatoid arthritis	0.000512	0.00543	CbGpPWpGaD
Cinacalcet—Immune system disorder—Prednisone—rheumatoid arthritis	0.000509	0.00171	CcSEcCtD
Cinacalcet—Arrhythmia—Prednisone—rheumatoid arthritis	0.000503	0.00169	CcSEcCtD
Cinacalcet—Infection—Triamcinolone—rheumatoid arthritis	0.000503	0.00169	CcSEcCtD
Cinacalcet—Hypotension—Hydrocortisone—rheumatoid arthritis	0.000503	0.00169	CcSEcCtD
Cinacalcet—Infection—Methylprednisolone—rheumatoid arthritis	0.000502	0.00169	CcSEcCtD
Cinacalcet—Vomiting—Leflunomide—rheumatoid arthritis	0.000499	0.00168	CcSEcCtD
Cinacalcet—Nervous system disorder—Methylprednisolone—rheumatoid arthritis	0.000496	0.00167	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Cyclosporine—rheumatoid arthritis	0.000495	0.00167	CcSEcCtD
Cinacalcet—Paraesthesia—Prednisolone—rheumatoid arthritis	0.000495	0.00167	CcSEcCtD
Cinacalcet—Rash—Leflunomide—rheumatoid arthritis	0.000495	0.00167	CcSEcCtD
Cinacalcet—Dermatitis—Leflunomide—rheumatoid arthritis	0.000494	0.00166	CcSEcCtD
Cinacalcet—Nausea—Azathioprine—rheumatoid arthritis	0.000493	0.00166	CcSEcCtD
Cinacalcet—CASR—Signaling by GPCR—IL2RB—rheumatoid arthritis	0.000492	0.00523	CbGpPWpGaD
Cinacalcet—CASR—GPCR downstream signaling—CCR6—rheumatoid arthritis	0.000492	0.00523	CbGpPWpGaD
Cinacalcet—Headache—Leflunomide—rheumatoid arthritis	0.000491	0.00165	CcSEcCtD
Cinacalcet—Skin disorder—Methylprednisolone—rheumatoid arthritis	0.000491	0.00165	CcSEcCtD
Cinacalcet—Malnutrition—Prednisone—rheumatoid arthritis	0.000491	0.00165	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Hydrocortisone—rheumatoid arthritis	0.00049	0.00165	CcSEcCtD
Cinacalcet—Convulsion—Dexamethasone—rheumatoid arthritis	0.000488	0.00164	CcSEcCtD
Cinacalcet—Convulsion—Betamethasone—rheumatoid arthritis	0.000488	0.00164	CcSEcCtD
Cinacalcet—Hypertension—Dexamethasone—rheumatoid arthritis	0.000486	0.00164	CcSEcCtD
Cinacalcet—Hypertension—Betamethasone—rheumatoid arthritis	0.000486	0.00164	CcSEcCtD
Cinacalcet—Paraesthesia—Hydrocortisone—rheumatoid arthritis	0.000483	0.00163	CcSEcCtD
Cinacalcet—Urticaria—Cyclosporine—rheumatoid arthritis	0.000481	0.00162	CcSEcCtD
Cinacalcet—Myalgia—Betamethasone—rheumatoid arthritis	0.00048	0.00161	CcSEcCtD
Cinacalcet—Myalgia—Dexamethasone—rheumatoid arthritis	0.00048	0.00161	CcSEcCtD
Cinacalcet—Abdominal pain—Cyclosporine—rheumatoid arthritis	0.000479	0.00161	CcSEcCtD
Cinacalcet—Body temperature increased—Cyclosporine—rheumatoid arthritis	0.000479	0.00161	CcSEcCtD
Cinacalcet—CASR—Signaling by GPCR—C5—rheumatoid arthritis	0.000476	0.00505	CbGpPWpGaD
Cinacalcet—Dyspepsia—Hydrocortisone—rheumatoid arthritis	0.000474	0.00159	CcSEcCtD
Cinacalcet—Hypotension—Methylprednisolone—rheumatoid arthritis	0.000472	0.00159	CcSEcCtD
Cinacalcet—Decreased appetite—Hydrocortisone—rheumatoid arthritis	0.000468	0.00157	CcSEcCtD
Cinacalcet—Nausea—Leflunomide—rheumatoid arthritis	0.000466	0.00157	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Hydrocortisone—rheumatoid arthritis	0.000465	0.00156	CcSEcCtD
Cinacalcet—CASR—GPCR ligand binding—CCR5—rheumatoid arthritis	0.000464	0.00493	CbGpPWpGaD
Cinacalcet—Fatigue—Hydrocortisone—rheumatoid arthritis	0.000464	0.00156	CcSEcCtD
Cinacalcet—CASR—G alpha (i) signalling events—CXCL8—rheumatoid arthritis	0.000464	0.00493	CbGpPWpGaD
Cinacalcet—Musculoskeletal discomfort—Triamcinolone—rheumatoid arthritis	0.000462	0.00155	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Methylprednisolone—rheumatoid arthritis	0.000461	0.00155	CcSEcCtD
Cinacalcet—Infection—Dexamethasone—rheumatoid arthritis	0.000457	0.00154	CcSEcCtD
Cinacalcet—Infection—Betamethasone—rheumatoid arthritis	0.000457	0.00154	CcSEcCtD
Cinacalcet—Paraesthesia—Triamcinolone—rheumatoid arthritis	0.000455	0.00153	CcSEcCtD
Cinacalcet—Paraesthesia—Methylprednisolone—rheumatoid arthritis	0.000454	0.00153	CcSEcCtD
Cinacalcet—CASR—GPCR ligand binding—C3—rheumatoid arthritis	0.000454	0.00482	CbGpPWpGaD
Cinacalcet—Anaemia—Prednisone—rheumatoid arthritis	0.000453	0.00153	CcSEcCtD
Cinacalcet—Dyspnoea—Triamcinolone—rheumatoid arthritis	0.000452	0.00152	CcSEcCtD
Cinacalcet—Nervous system disorder—Dexamethasone—rheumatoid arthritis	0.000451	0.00152	CcSEcCtD
Cinacalcet—Nervous system disorder—Betamethasone—rheumatoid arthritis	0.000451	0.00152	CcSEcCtD
Cinacalcet—CASR—GPCR downstream signaling—CXCL2—rheumatoid arthritis	0.00045	0.00478	CbGpPWpGaD
Cinacalcet—Angioedema—Prednisone—rheumatoid arthritis	0.000448	0.00151	CcSEcCtD
Cinacalcet—CASR—Signaling by GPCR—CCR6—rheumatoid arthritis	0.000447	0.00475	CbGpPWpGaD
Cinacalcet—Hypersensitivity—Cyclosporine—rheumatoid arthritis	0.000446	0.0015	CcSEcCtD
Cinacalcet—Dyspepsia—Triamcinolone—rheumatoid arthritis	0.000446	0.0015	CcSEcCtD
Cinacalcet—Dyspepsia—Methylprednisolone—rheumatoid arthritis	0.000445	0.0015	CcSEcCtD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—AHR—rheumatoid arthritis	0.000442	0.0047	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor Pathway—AHR—rheumatoid arthritis	0.000442	0.0047	CbGpPWpGaD
Cinacalcet—CASR—GPCR downstream signaling—SAA1—rheumatoid arthritis	0.00044	0.00468	CbGpPWpGaD
Cinacalcet—Gastrointestinal pain—Hydrocortisone—rheumatoid arthritis	0.00044	0.00148	CcSEcCtD
Cinacalcet—Anorexia—Betamethasone—rheumatoid arthritis	0.000438	0.00148	CcSEcCtD
Cinacalcet—Anorexia—Dexamethasone—rheumatoid arthritis	0.000438	0.00148	CcSEcCtD
Cinacalcet—Urticaria—Prednisolone—rheumatoid arthritis	0.000438	0.00147	CcSEcCtD
Cinacalcet—Fatigue—Triamcinolone—rheumatoid arthritis	0.000437	0.00147	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—PDE2A—rheumatoid arthritis	0.000436	0.00463	CbGpPWpGaD
Cinacalcet—Fatigue—Methylprednisolone—rheumatoid arthritis	0.000436	0.00147	CcSEcCtD
Cinacalcet—Asthenia—Cyclosporine—rheumatoid arthritis	0.000434	0.00146	CcSEcCtD
Cinacalcet—Hypotension—Betamethasone—rheumatoid arthritis	0.00043	0.00145	CcSEcCtD
Cinacalcet—Hypotension—Dexamethasone—rheumatoid arthritis	0.00043	0.00145	CcSEcCtD
Cinacalcet—Pruritus—Cyclosporine—rheumatoid arthritis	0.000428	0.00144	CcSEcCtD
Cinacalcet—Urticaria—Hydrocortisone—rheumatoid arthritis	0.000427	0.00144	CcSEcCtD
Cinacalcet—Immune system disorder—Methotrexate—rheumatoid arthritis	0.000425	0.00143	CcSEcCtD
Cinacalcet—Abdominal pain—Hydrocortisone—rheumatoid arthritis	0.000425	0.00143	CcSEcCtD
Cinacalcet—Body temperature increased—Hydrocortisone—rheumatoid arthritis	0.000425	0.00143	CcSEcCtD
Cinacalcet—Convulsion—Prednisone—rheumatoid arthritis	0.000425	0.00143	CcSEcCtD
Cinacalcet—Hypertension—Prednisone—rheumatoid arthritis	0.000424	0.00143	CcSEcCtD
Cinacalcet—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—rheumatoid arthritis	0.00042	0.00446	CbGpPWpGaD
Cinacalcet—Musculoskeletal discomfort—Dexamethasone—rheumatoid arthritis	0.000419	0.00141	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Betamethasone—rheumatoid arthritis	0.000419	0.00141	CcSEcCtD
Cinacalcet—Myalgia—Prednisone—rheumatoid arthritis	0.000418	0.00141	CcSEcCtD
Cinacalcet—Arthralgia—Prednisone—rheumatoid arthritis	0.000418	0.00141	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—PLB1—rheumatoid arthritis	0.000416	0.00442	CbGpPWpGaD
Cinacalcet—Unspecified disorder of skin and subcutaneous tissue—Prednisone—rheumatoid arthritis	0.000415	0.0014	CcSEcCtD
Cinacalcet—Diarrhoea—Cyclosporine—rheumatoid arthritis	0.000414	0.00139	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Methylprednisolone—rheumatoid arthritis	0.000413	0.00139	CcSEcCtD
Cinacalcet—Paraesthesia—Dexamethasone—rheumatoid arthritis	0.000413	0.00139	CcSEcCtD
Cinacalcet—Paraesthesia—Betamethasone—rheumatoid arthritis	0.000413	0.00139	CcSEcCtD
Cinacalcet—Malnutrition—Methotrexate—rheumatoid arthritis	0.00041	0.00138	CcSEcCtD
Cinacalcet—CASR—Signaling by GPCR—CCL3—rheumatoid arthritis	0.000409	0.00434	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—CXCL2—rheumatoid arthritis	0.000409	0.00434	CbGpPWpGaD
Cinacalcet—Hypersensitivity—Prednisolone—rheumatoid arthritis	0.000406	0.00137	CcSEcCtD
Cinacalcet—Dyspepsia—Betamethasone—rheumatoid arthritis	0.000405	0.00136	CcSEcCtD
Cinacalcet—Dyspepsia—Dexamethasone—rheumatoid arthritis	0.000405	0.00136	CcSEcCtD
Cinacalcet—CYP1A2—Arachidonic acid metabolism—ALOX5—rheumatoid arthritis	0.000403	0.00428	CbGpPWpGaD
Cinacalcet—Urticaria—Triamcinolone—rheumatoid arthritis	0.000403	0.00136	CcSEcCtD
Cinacalcet—Urticaria—Methylprednisolone—rheumatoid arthritis	0.000402	0.00135	CcSEcCtD
Cinacalcet—Body temperature increased—Triamcinolone—rheumatoid arthritis	0.000401	0.00135	CcSEcCtD
Cinacalcet—Dizziness—Cyclosporine—rheumatoid arthritis	0.0004	0.00135	CcSEcCtD
Cinacalcet—CASR—Signaling by GPCR—SAA1—rheumatoid arthritis	0.0004	0.00425	CbGpPWpGaD
Cinacalcet—Abdominal pain—Methylprednisolone—rheumatoid arthritis	0.0004	0.00135	CcSEcCtD
Cinacalcet—Decreased appetite—Dexamethasone—rheumatoid arthritis	0.0004	0.00135	CcSEcCtD
Cinacalcet—Decreased appetite—Betamethasone—rheumatoid arthritis	0.0004	0.00135	CcSEcCtD
Cinacalcet—Infection—Prednisone—rheumatoid arthritis	0.000398	0.00134	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Dexamethasone—rheumatoid arthritis	0.000397	0.00134	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Betamethasone—rheumatoid arthritis	0.000397	0.00134	CcSEcCtD
Cinacalcet—Hypersensitivity—Hydrocortisone—rheumatoid arthritis	0.000396	0.00133	CcSEcCtD
Cinacalcet—Fatigue—Betamethasone—rheumatoid arthritis	0.000396	0.00133	CcSEcCtD
Cinacalcet—Fatigue—Dexamethasone—rheumatoid arthritis	0.000396	0.00133	CcSEcCtD
Cinacalcet—Floctafenine—PTGS2—rheumatoid arthritis	0.000393	0.761	CrCbGaD
Cinacalcet—Nervous system disorder—Prednisone—rheumatoid arthritis	0.000393	0.00132	CcSEcCtD
Cinacalcet—Skin disorder—Prednisone—rheumatoid arthritis	0.000389	0.00131	CcSEcCtD
Cinacalcet—Asthenia—Hydrocortisone—rheumatoid arthritis	0.000386	0.0013	CcSEcCtD
Cinacalcet—Vomiting—Cyclosporine—rheumatoid arthritis	0.000385	0.0013	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—RBPJ—rheumatoid arthritis	0.000384	0.00408	CbGpPWpGaD
Cinacalcet—CASR—GPCR downstream signaling—BDKRB2—rheumatoid arthritis	0.000383	0.00407	CbGpPWpGaD
Cinacalcet—CASR—GPCR downstream signaling—CXCL12—rheumatoid arthritis	0.000383	0.00407	CbGpPWpGaD
Cinacalcet—Rash—Cyclosporine—rheumatoid arthritis	0.000382	0.00129	CcSEcCtD
Cinacalcet—Anorexia—Prednisone—rheumatoid arthritis	0.000382	0.00128	CcSEcCtD
Cinacalcet—Dermatitis—Cyclosporine—rheumatoid arthritis	0.000381	0.00128	CcSEcCtD
Cinacalcet—Pruritus—Hydrocortisone—rheumatoid arthritis	0.000381	0.00128	CcSEcCtD
Cinacalcet—Headache—Cyclosporine—rheumatoid arthritis	0.000379	0.00128	CcSEcCtD
Cinacalcet—Anaemia—Methotrexate—rheumatoid arthritis	0.000379	0.00128	CcSEcCtD
Cinacalcet—CASR—GPCR downstream signaling—ADRBK1—rheumatoid arthritis	0.000379	0.00402	CbGpPWpGaD
Cinacalcet—Gastrointestinal pain—Dexamethasone—rheumatoid arthritis	0.000376	0.00127	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Betamethasone—rheumatoid arthritis	0.000376	0.00127	CcSEcCtD
Cinacalcet—Hypersensitivity—Triamcinolone—rheumatoid arthritis	0.000373	0.00126	CcSEcCtD
Cinacalcet—Hypersensitivity—Methylprednisolone—rheumatoid arthritis	0.000372	0.00125	CcSEcCtD
Cinacalcet—Diarrhoea—Hydrocortisone—rheumatoid arthritis	0.000368	0.00124	CcSEcCtD
Cinacalcet—Urticaria—Dexamethasone—rheumatoid arthritis	0.000365	0.00123	CcSEcCtD
Cinacalcet—Urticaria—Betamethasone—rheumatoid arthritis	0.000365	0.00123	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Prednisone—rheumatoid arthritis	0.000365	0.00123	CcSEcCtD
Cinacalcet—Dizziness—Prednisolone—rheumatoid arthritis	0.000364	0.00123	CcSEcCtD
Cinacalcet—Asthenia—Triamcinolone—rheumatoid arthritis	0.000364	0.00122	CcSEcCtD
Cinacalcet—Body temperature increased—Betamethasone—rheumatoid arthritis	0.000363	0.00122	CcSEcCtD
Cinacalcet—Body temperature increased—Dexamethasone—rheumatoid arthritis	0.000363	0.00122	CcSEcCtD
Cinacalcet—Abdominal pain—Dexamethasone—rheumatoid arthritis	0.000363	0.00122	CcSEcCtD
Cinacalcet—Abdominal pain—Betamethasone—rheumatoid arthritis	0.000363	0.00122	CcSEcCtD
Cinacalcet—CASR—GPCR ligand binding—POMC—rheumatoid arthritis	0.000363	0.00386	CbGpPWpGaD
Cinacalcet—Asthenia—Methylprednisolone—rheumatoid arthritis	0.000363	0.00122	CcSEcCtD
Cinacalcet—Nausea—Cyclosporine—rheumatoid arthritis	0.00036	0.00121	CcSEcCtD
Cinacalcet—Paraesthesia—Prednisone—rheumatoid arthritis	0.00036	0.00121	CcSEcCtD
Cinacalcet—Pruritus—Triamcinolone—rheumatoid arthritis	0.000358	0.00121	CcSEcCtD
Cinacalcet—Cough—Methotrexate—rheumatoid arthritis	0.000358	0.0012	CcSEcCtD
Cinacalcet—Pruritus—Methylprednisolone—rheumatoid arthritis	0.000358	0.0012	CcSEcCtD
Cinacalcet—CASR—GPCR downstream signaling—RASGRP1—rheumatoid arthritis	0.000357	0.00379	CbGpPWpGaD
Cinacalcet—Dizziness—Hydrocortisone—rheumatoid arthritis	0.000356	0.0012	CcSEcCtD
Cinacalcet—Convulsion—Methotrexate—rheumatoid arthritis	0.000355	0.0012	CcSEcCtD
Cinacalcet—CASR—GPCR ligand binding—CCL2—rheumatoid arthritis	0.000355	0.00377	CbGpPWpGaD
Cinacalcet—Dyspepsia—Prednisone—rheumatoid arthritis	0.000352	0.00119	CcSEcCtD
Cinacalcet—CASR—GPCR downstream signaling—PRKCQ—rheumatoid arthritis	0.000349	0.00371	CbGpPWpGaD
Cinacalcet—Myalgia—Methotrexate—rheumatoid arthritis	0.000349	0.00118	CcSEcCtD
Cinacalcet—Chest pain—Methotrexate—rheumatoid arthritis	0.000349	0.00118	CcSEcCtD
Cinacalcet—Arthralgia—Methotrexate—rheumatoid arthritis	0.000349	0.00118	CcSEcCtD
Cinacalcet—Decreased appetite—Prednisone—rheumatoid arthritis	0.000348	0.00117	CcSEcCtD
Cinacalcet—CASR—Signaling by GPCR—CXCL12—rheumatoid arthritis	0.000348	0.00369	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—BDKRB2—rheumatoid arthritis	0.000348	0.00369	CbGpPWpGaD
Cinacalcet—Rash—Prednisolone—rheumatoid arthritis	0.000347	0.00117	CcSEcCtD
Cinacalcet—Dermatitis—Prednisolone—rheumatoid arthritis	0.000347	0.00117	CcSEcCtD
Cinacalcet—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—rheumatoid arthritis	0.000347	0.00117	CcSEcCtD
Cinacalcet—Diarrhoea—Methylprednisolone—rheumatoid arthritis	0.000346	0.00116	CcSEcCtD
Cinacalcet—Fatigue—Prednisone—rheumatoid arthritis	0.000345	0.00116	CcSEcCtD
Cinacalcet—Headache—Prednisolone—rheumatoid arthritis	0.000345	0.00116	CcSEcCtD
Cinacalcet—CASR—Signaling by GPCR—ADRBK1—rheumatoid arthritis	0.000344	0.00365	CbGpPWpGaD
Cinacalcet—Constipation—Prednisone—rheumatoid arthritis	0.000342	0.00115	CcSEcCtD
Cinacalcet—Vomiting—Hydrocortisone—rheumatoid arthritis	0.000342	0.00115	CcSEcCtD
Cinacalcet—Rash—Hydrocortisone—rheumatoid arthritis	0.000339	0.00114	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—CXCL13—rheumatoid arthritis	0.000339	0.0036	CbGpPWpGaD
Cinacalcet—Dermatitis—Hydrocortisone—rheumatoid arthritis	0.000339	0.00114	CcSEcCtD
Cinacalcet—CASR—GPCR downstream signaling—CXCL10—rheumatoid arthritis	0.000338	0.0036	CbGpPWpGaD
Cinacalcet—Headache—Hydrocortisone—rheumatoid arthritis	0.000337	0.00113	CcSEcCtD
Cinacalcet—Dizziness—Triamcinolone—rheumatoid arthritis	0.000335	0.00113	CcSEcCtD
Cinacalcet—Dizziness—Methylprednisolone—rheumatoid arthritis	0.000334	0.00113	CcSEcCtD
Cinacalcet—Infection—Methotrexate—rheumatoid arthritis	0.000332	0.00112	CcSEcCtD
Cinacalcet—Asthenia—Betamethasone—rheumatoid arthritis	0.00033	0.00111	CcSEcCtD
Cinacalcet—Asthenia—Dexamethasone—rheumatoid arthritis	0.00033	0.00111	CcSEcCtD
Cinacalcet—Nervous system disorder—Methotrexate—rheumatoid arthritis	0.000328	0.0011	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Prednisone—rheumatoid arthritis	0.000327	0.0011	CcSEcCtD
Cinacalcet—Nausea—Prednisolone—rheumatoid arthritis	0.000327	0.0011	CcSEcCtD
Cinacalcet—Pruritus—Betamethasone—rheumatoid arthritis	0.000325	0.00109	CcSEcCtD
Cinacalcet—Pruritus—Dexamethasone—rheumatoid arthritis	0.000325	0.00109	CcSEcCtD
Cinacalcet—Skin disorder—Methotrexate—rheumatoid arthritis	0.000325	0.00109	CcSEcCtD
Cinacalcet—CASR—Signaling by GPCR—RASGRP1—rheumatoid arthritis	0.000324	0.00345	CbGpPWpGaD
Cinacalcet—Vomiting—Triamcinolone—rheumatoid arthritis	0.000322	0.00108	CcSEcCtD
Cinacalcet—Vomiting—Methylprednisolone—rheumatoid arthritis	0.000321	0.00108	CcSEcCtD
Cinacalcet—Nausea—Hydrocortisone—rheumatoid arthritis	0.00032	0.00108	CcSEcCtD
Cinacalcet—Rash—Triamcinolone—rheumatoid arthritis	0.000319	0.00108	CcSEcCtD
Cinacalcet—Dermatitis—Triamcinolone—rheumatoid arthritis	0.000319	0.00107	CcSEcCtD
Cinacalcet—Anorexia—Methotrexate—rheumatoid arthritis	0.000319	0.00107	CcSEcCtD
Cinacalcet—Rash—Methylprednisolone—rheumatoid arthritis	0.000319	0.00107	CcSEcCtD
Cinacalcet—Dermatitis—Methylprednisolone—rheumatoid arthritis	0.000318	0.00107	CcSEcCtD
Cinacalcet—Urticaria—Prednisone—rheumatoid arthritis	0.000318	0.00107	CcSEcCtD
Cinacalcet—Headache—Triamcinolone—rheumatoid arthritis	0.000317	0.00107	CcSEcCtD
Cinacalcet—CASR—Signaling by GPCR—PRKCQ—rheumatoid arthritis	0.000317	0.00337	CbGpPWpGaD
Cinacalcet—Headache—Methylprednisolone—rheumatoid arthritis	0.000317	0.00107	CcSEcCtD
Cinacalcet—Abdominal pain—Prednisone—rheumatoid arthritis	0.000316	0.00107	CcSEcCtD
Cinacalcet—Body temperature increased—Prednisone—rheumatoid arthritis	0.000316	0.00107	CcSEcCtD
Cinacalcet—Diarrhoea—Dexamethasone—rheumatoid arthritis	0.000315	0.00106	CcSEcCtD
Cinacalcet—Diarrhoea—Betamethasone—rheumatoid arthritis	0.000315	0.00106	CcSEcCtD
Cinacalcet—Hypotension—Methotrexate—rheumatoid arthritis	0.000313	0.00105	CcSEcCtD
Cinacalcet—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—rheumatoid arthritis	0.000313	0.00332	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—CXCL10—rheumatoid arthritis	0.000307	0.00326	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—TLE3—rheumatoid arthritis	0.000305	0.00324	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—IRAK1—rheumatoid arthritis	0.000305	0.00324	CbGpPWpGaD
Cinacalcet—Musculoskeletal discomfort—Methotrexate—rheumatoid arthritis	0.000305	0.00103	CcSEcCtD
Cinacalcet—Dizziness—Dexamethasone—rheumatoid arthritis	0.000304	0.00102	CcSEcCtD
Cinacalcet—Dizziness—Betamethasone—rheumatoid arthritis	0.000304	0.00102	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—CX3CR1—rheumatoid arthritis	0.000302	0.00321	CbGpPWpGaD
Cinacalcet—Nausea—Triamcinolone—rheumatoid arthritis	0.000301	0.00101	CcSEcCtD
Cinacalcet—Paraesthesia—Methotrexate—rheumatoid arthritis	0.0003	0.00101	CcSEcCtD
Cinacalcet—Nausea—Methylprednisolone—rheumatoid arthritis	0.0003	0.00101	CcSEcCtD
Cinacalcet—Dyspnoea—Methotrexate—rheumatoid arthritis	0.000298	0.001	CcSEcCtD
Cinacalcet—Hypersensitivity—Prednisone—rheumatoid arthritis	0.000295	0.000993	CcSEcCtD
Cinacalcet—Dyspepsia—Methotrexate—rheumatoid arthritis	0.000295	0.000992	CcSEcCtD
Cinacalcet—Vomiting—Dexamethasone—rheumatoid arthritis	0.000292	0.000984	CcSEcCtD
Cinacalcet—Vomiting—Betamethasone—rheumatoid arthritis	0.000292	0.000984	CcSEcCtD
Cinacalcet—CASR—GPCR downstream signaling—CCL5—rheumatoid arthritis	0.000291	0.00309	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—IL2RB—rheumatoid arthritis	0.000291	0.00309	CbGpPWpGaD
Cinacalcet—Decreased appetite—Methotrexate—rheumatoid arthritis	0.000291	0.000979	CcSEcCtD
Cinacalcet—Rash—Dexamethasone—rheumatoid arthritis	0.00029	0.000976	CcSEcCtD
Cinacalcet—Rash—Betamethasone—rheumatoid arthritis	0.00029	0.000976	CcSEcCtD
Cinacalcet—Dermatitis—Dexamethasone—rheumatoid arthritis	0.00029	0.000975	CcSEcCtD
Cinacalcet—Dermatitis—Betamethasone—rheumatoid arthritis	0.00029	0.000975	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Methotrexate—rheumatoid arthritis	0.000289	0.000972	CcSEcCtD
Cinacalcet—Fatigue—Methotrexate—rheumatoid arthritis	0.000288	0.000971	CcSEcCtD
Cinacalcet—Headache—Dexamethasone—rheumatoid arthritis	0.000288	0.00097	CcSEcCtD
Cinacalcet—Headache—Betamethasone—rheumatoid arthritis	0.000288	0.00097	CcSEcCtD
Cinacalcet—Asthenia—Prednisone—rheumatoid arthritis	0.000287	0.000967	CcSEcCtD
Cinacalcet—CASR—GPCR downstream signaling—CSF2—rheumatoid arthritis	0.000287	0.00305	CbGpPWpGaD
Cinacalcet—Pruritus—Prednisone—rheumatoid arthritis	0.000283	0.000954	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—C5—rheumatoid arthritis	0.000281	0.00298	CbGpPWpGaD
Cinacalcet—CASR—GPCR ligand binding—CXCL8—rheumatoid arthritis	0.000281	0.00298	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—MMP3—rheumatoid arthritis	0.00028	0.00298	CbGpPWpGaD
Cinacalcet—CASR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—rheumatoid arthritis	0.00028	0.00297	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—NFATC1—rheumatoid arthritis	0.000276	0.00294	CbGpPWpGaD
Cinacalcet—Diarrhoea—Prednisone—rheumatoid arthritis	0.000274	0.000922	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Methotrexate—rheumatoid arthritis	0.000274	0.000921	CcSEcCtD
Cinacalcet—Nausea—Betamethasone—rheumatoid arthritis	0.000273	0.000919	CcSEcCtD
Cinacalcet—Nausea—Dexamethasone—rheumatoid arthritis	0.000273	0.000919	CcSEcCtD
Cinacalcet—Urticaria—Methotrexate—rheumatoid arthritis	0.000266	0.000895	CcSEcCtD
Cinacalcet—Dizziness—Prednisone—rheumatoid arthritis	0.000265	0.000891	CcSEcCtD
Cinacalcet—CASR—Signaling by GPCR—CCL5—rheumatoid arthritis	0.000265	0.00281	CbGpPWpGaD
Cinacalcet—Body temperature increased—Methotrexate—rheumatoid arthritis	0.000265	0.00089	CcSEcCtD
Cinacalcet—Abdominal pain—Methotrexate—rheumatoid arthritis	0.000265	0.00089	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—CCR6—rheumatoid arthritis	0.000264	0.00281	CbGpPWpGaD
Cinacalcet—CASR—GPCR downstream signaling—CCR5—rheumatoid arthritis	0.000262	0.00279	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—CSF2—rheumatoid arthritis	0.000261	0.00277	CbGpPWpGaD
Cinacalcet—CASR—GPCR downstream signaling—IL2RA—rheumatoid arthritis	0.000259	0.00275	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—NCF2—rheumatoid arthritis	0.000257	0.00273	CbGpPWpGaD
Cinacalcet—CASR—GPCR downstream signaling—C3—rheumatoid arthritis	0.000256	0.00272	CbGpPWpGaD
Cinacalcet—Vomiting—Prednisone—rheumatoid arthritis	0.000255	0.000857	CcSEcCtD
Cinacalcet—CYP1A2—Tryptophan metabolism—CAT—rheumatoid arthritis	0.000253	0.00269	CbGpPWpGaD
Cinacalcet—Rash—Prednisone—rheumatoid arthritis	0.000252	0.00085	CcSEcCtD
Cinacalcet—Dermatitis—Prednisone—rheumatoid arthritis	0.000252	0.000849	CcSEcCtD
Cinacalcet—Headache—Prednisone—rheumatoid arthritis	0.000251	0.000844	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—SH2B3—rheumatoid arthritis	0.00025	0.00266	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—TRAF6—rheumatoid arthritis	0.00025	0.00266	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—GZMB—rheumatoid arthritis	0.000249	0.00264	CbGpPWpGaD
Cinacalcet—Hypersensitivity—Methotrexate—rheumatoid arthritis	0.000247	0.00083	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—CCL3—rheumatoid arthritis	0.000242	0.00257	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—CXCL2—rheumatoid arthritis	0.000242	0.00257	CbGpPWpGaD
Cinacalcet—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—rheumatoid arthritis	0.000241	0.00256	CbGpPWpGaD
Cinacalcet—Asthenia—Methotrexate—rheumatoid arthritis	0.00024	0.000808	CcSEcCtD
Cinacalcet—CASR—Signaling by GPCR—CCR5—rheumatoid arthritis	0.000238	0.00253	CbGpPWpGaD
Cinacalcet—Nausea—Prednisone—rheumatoid arthritis	0.000238	0.000801	CcSEcCtD
Cinacalcet—Pruritus—Methotrexate—rheumatoid arthritis	0.000237	0.000797	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—SAA1—rheumatoid arthritis	0.000236	0.00251	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—IL2RA—rheumatoid arthritis	0.000235	0.0025	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—C3—rheumatoid arthritis	0.000233	0.00247	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—NCF1—rheumatoid arthritis	0.000231	0.00246	CbGpPWpGaD
Cinacalcet—Diarrhoea—Methotrexate—rheumatoid arthritis	0.000229	0.000771	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—CD28—rheumatoid arthritis	0.000223	0.00236	CbGpPWpGaD
Cinacalcet—Dizziness—Methotrexate—rheumatoid arthritis	0.000221	0.000745	CcSEcCtD
Cinacalcet—Vomiting—Methotrexate—rheumatoid arthritis	0.000213	0.000716	CcSEcCtD
Cinacalcet—Rash—Methotrexate—rheumatoid arthritis	0.000211	0.00071	CcSEcCtD
Cinacalcet—Dermatitis—Methotrexate—rheumatoid arthritis	0.000211	0.00071	CcSEcCtD
Cinacalcet—Headache—Methotrexate—rheumatoid arthritis	0.00021	0.000706	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—UBE2D1—rheumatoid arthritis	0.000209	0.00223	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—CXCL12—rheumatoid arthritis	0.000205	0.00218	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—BDKRB2—rheumatoid arthritis	0.000205	0.00218	CbGpPWpGaD
Cinacalcet—CASR—GPCR downstream signaling—POMC—rheumatoid arthritis	0.000205	0.00218	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—IL6ST—rheumatoid arthritis	0.000204	0.00216	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—ADRBK1—rheumatoid arthritis	0.000203	0.00216	CbGpPWpGaD
Cinacalcet—CYP2D6—Melatonin metabolism and effects—NFKB1—rheumatoid arthritis	0.000199	0.00212	CbGpPWpGaD
Cinacalcet—Nausea—Methotrexate—rheumatoid arthritis	0.000199	0.000669	CcSEcCtD
Cinacalcet—CYP3A4—Tryptophan metabolism—CAT—rheumatoid arthritis	0.000195	0.00207	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—RASGRP1—rheumatoid arthritis	0.000192	0.00204	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—SYK—rheumatoid arthritis	0.000191	0.00203	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—PRKCQ—rheumatoid arthritis	0.000187	0.00199	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—POMC—rheumatoid arthritis	0.000186	0.00198	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—STAT1—rheumatoid arthritis	0.000184	0.00196	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—CCL2—rheumatoid arthritis	0.000182	0.00194	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—IL6R—rheumatoid arthritis	0.000182	0.00193	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—CXCL10—rheumatoid arthritis	0.000182	0.00193	CbGpPWpGaD
Cinacalcet—CYP1A2—Melatonin metabolism and effects—NFKB1—rheumatoid arthritis	0.000169	0.00179	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—MMP3—rheumatoid arthritis	0.000166	0.00176	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—TYK2—rheumatoid arthritis	0.000166	0.00176	CbGpPWpGaD
Cinacalcet—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—rheumatoid arthritis	0.000161	0.00171	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—PTK2—rheumatoid arthritis	0.000159	0.00169	CbGpPWpGaD
Cinacalcet—CASR—GPCR downstream signaling—CXCL8—rheumatoid arthritis	0.000159	0.00169	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—CCL5—rheumatoid arthritis	0.000156	0.00166	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—FADS2—rheumatoid arthritis	0.000156	0.00165	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—CSF2—rheumatoid arthritis	0.000154	0.00164	CbGpPWpGaD
Cinacalcet—CASR—GPCR downstream signaling—IL2—rheumatoid arthritis	0.000152	0.00161	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—SPP1—rheumatoid arthritis	0.000145	0.00154	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—CXCL8—rheumatoid arthritis	0.000144	0.00153	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—CCR5—rheumatoid arthritis	0.000141	0.0015	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—rheumatoid arthritis	0.00014	0.00149	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—IL2RA—rheumatoid arthritis	0.000139	0.00147	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—IL2—rheumatoid arthritis	0.000138	0.00146	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—C3—rheumatoid arthritis	0.000138	0.00146	CbGpPWpGaD
Cinacalcet—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—rheumatoid arthritis	0.000136	0.00145	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—rheumatoid arthritis	0.000135	0.00143	CbGpPWpGaD
Cinacalcet—CYP2D6—Phase 1 - Functionalization of compounds—POMC—rheumatoid arthritis	0.000131	0.00139	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—LEP—rheumatoid arthritis	0.000128	0.00136	CbGpPWpGaD
Cinacalcet—CYP1A2—Arachidonic acid metabolism—PTGS2—rheumatoid arthritis	0.000126	0.00134	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—rheumatoid arthritis	0.000125	0.00133	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—rheumatoid arthritis	0.000125	0.00133	CbGpPWpGaD
Cinacalcet—Fluoxetine—ALB—rheumatoid arthritis	0.000124	0.239	CrCbGaD
Cinacalcet—CASR—Signaling Pathways—FN1—rheumatoid arthritis	0.000121	0.00128	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—IL6ST—rheumatoid arthritis	0.00012	0.00128	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—rheumatoid arthritis	0.000117	0.00124	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—CD80—rheumatoid arthritis	0.000116	0.00123	CbGpPWpGaD
Cinacalcet—CYP1A2—Phase 1 - Functionalization of compounds—POMC—rheumatoid arthritis	0.000111	0.00117	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—POMC—rheumatoid arthritis	0.00011	0.00117	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—CCL2—rheumatoid arthritis	0.000108	0.00114	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—IL6R—rheumatoid arthritis	0.000107	0.00114	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—rheumatoid arthritis	0.000106	0.00113	CbGpPWpGaD
Cinacalcet—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—rheumatoid arthritis	0.000105	0.00112	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—PLD4—rheumatoid arthritis	0.000104	0.0011	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—TYK2—rheumatoid arthritis	9.78e-05	0.00104	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—rheumatoid arthritis	9.73e-05	0.00103	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—NOS3—rheumatoid arthritis	9.6e-05	0.00102	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—PTGES—rheumatoid arthritis	9.17e-05	0.000974	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—GC—rheumatoid arthritis	9.17e-05	0.000974	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—rheumatoid arthritis	9.09e-05	0.000965	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—TNF—rheumatoid arthritis	9.09e-05	0.000965	CbGpPWpGaD
Cinacalcet—CYP3A4—Phase 1 - Functionalization of compounds—POMC—rheumatoid arthritis	8.54e-05	0.000907	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—PLB1—rheumatoid arthritis	8.53e-05	0.000906	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—CXCL8—rheumatoid arthritis	8.51e-05	0.000904	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—FADS2—rheumatoid arthritis	8.18e-05	0.000869	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—IL2—rheumatoid arthritis	8.14e-05	0.000864	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—IL6—rheumatoid arthritis	8.09e-05	0.00086	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—MMP9—rheumatoid arthritis	7.7e-05	0.000818	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—NFKB1—rheumatoid arthritis	7.62e-05	0.000809	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—MAPK8—rheumatoid arthritis	7.49e-05	0.000795	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—MED1—rheumatoid arthritis	7.48e-05	0.000794	CbGpPWpGaD
Cinacalcet—CYP2D6—Biological oxidations—POMC—rheumatoid arthritis	6.93e-05	0.000737	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—FADS2—rheumatoid arthritis	6.93e-05	0.000736	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—VEGFA—rheumatoid arthritis	6.91e-05	0.000734	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—TGFB1—rheumatoid arthritis	6.35e-05	0.000674	CbGpPWpGaD
Cinacalcet—CYP1A2—Biological oxidations—POMC—rheumatoid arthritis	5.87e-05	0.000624	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5—rheumatoid arthritis	5.76e-05	0.000612	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—PLD4—rheumatoid arthritis	5.46e-05	0.00058	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—FADS2—rheumatoid arthritis	5.35e-05	0.000568	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—ACAN—rheumatoid arthritis	5.27e-05	0.00056	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—TP53—rheumatoid arthritis	5.22e-05	0.000555	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—SLC25A12—rheumatoid arthritis	4.96e-05	0.000527	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—PTGES—rheumatoid arthritis	4.82e-05	0.000512	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—GC—rheumatoid arthritis	4.82e-05	0.000512	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—IL6—rheumatoid arthritis	4.78e-05	0.000508	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—PLD4—rheumatoid arthritis	4.62e-05	0.000491	CbGpPWpGaD
Cinacalcet—CYP3A4—Biological oxidations—POMC—rheumatoid arthritis	4.53e-05	0.000482	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—PLB1—rheumatoid arthritis	4.48e-05	0.000476	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—ACAN—rheumatoid arthritis	4.47e-05	0.000474	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—SLC25A12—rheumatoid arthritis	4.2e-05	0.000446	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—GC—rheumatoid arthritis	4.08e-05	0.000434	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—PTGES—rheumatoid arthritis	4.08e-05	0.000434	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—MED1—rheumatoid arthritis	3.93e-05	0.000418	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—PLB1—rheumatoid arthritis	3.8e-05	0.000403	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—B3GNT2—rheumatoid arthritis	3.65e-05	0.000388	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—ACP5—rheumatoid arthritis	3.65e-05	0.000388	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—PLD4—rheumatoid arthritis	3.57e-05	0.000379	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—ACAN—rheumatoid arthritis	3.45e-05	0.000366	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—MED1—rheumatoid arthritis	3.33e-05	0.000354	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—BGN—rheumatoid arthritis	3.29e-05	0.00035	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—SLC25A12—rheumatoid arthritis	3.24e-05	0.000344	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—GC—rheumatoid arthritis	3.15e-05	0.000335	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—PTGES—rheumatoid arthritis	3.15e-05	0.000335	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—B3GNT2—rheumatoid arthritis	3.1e-05	0.000329	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—ACP5—rheumatoid arthritis	3.1e-05	0.000329	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—ALOX5—rheumatoid arthritis	3.03e-05	0.000322	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—PLB1—rheumatoid arthritis	2.93e-05	0.000311	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—BGN—rheumatoid arthritis	2.79e-05	0.000296	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—MED1—rheumatoid arthritis	2.57e-05	0.000273	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—ALOX5—rheumatoid arthritis	2.57e-05	0.000272	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—ENO1—rheumatoid arthritis	2.47e-05	0.000262	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—B3GNT2—rheumatoid arthritis	2.39e-05	0.000254	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—ACP5—rheumatoid arthritis	2.39e-05	0.000254	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	2.26e-05	0.00024	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—BGN—rheumatoid arthritis	2.15e-05	0.000229	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—ENO1—rheumatoid arthritis	2.09e-05	0.000222	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	2.06e-05	0.000218	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—ALOX5—rheumatoid arthritis	1.98e-05	0.00021	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	1.8e-05	0.000191	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—CAT—rheumatoid arthritis	1.78e-05	0.000189	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—ENO1—rheumatoid arthritis	1.61e-05	0.000171	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—CAT—rheumatoid arthritis	1.51e-05	0.00016	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—MTHFR—rheumatoid arthritis	1.48e-05	0.000158	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—MTHFR—rheumatoid arthritis	1.26e-05	0.000133	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—POMC—rheumatoid arthritis	1.19e-05	0.000126	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—CAT—rheumatoid arthritis	1.16e-05	0.000123	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—ALB—rheumatoid arthritis	1.08e-05	0.000115	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—NOS3—rheumatoid arthritis	1.03e-05	0.00011	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—POMC—rheumatoid arthritis	1e-05	0.000107	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—MTHFR—rheumatoid arthritis	9.7e-06	0.000103	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—PTGS2—rheumatoid arthritis	9.46e-06	0.0001	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—ALB—rheumatoid arthritis	9.16e-06	9.73e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—NOS3—rheumatoid arthritis	8.76e-06	9.31e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—PTGS2—rheumatoid arthritis	8.01e-06	8.51e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—POMC—rheumatoid arthritis	7.75e-06	8.24e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—ALB—rheumatoid arthritis	7.07e-06	7.51e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—NOS3—rheumatoid arthritis	6.76e-06	7.18e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—PTGS2—rheumatoid arthritis	6.18e-06	6.57e-05	CbGpPWpGaD
